Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loratadine for G-CSF-related Bone Pain Prevention
NCT05421416Phase 2Recruiting
- Sponsor
- American Health Staffing Group
- Start
- Nov 2024
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial in bone pain comparing Loratadine Arm with Placebo Arm (2 arms). Primary endpoints: Bone Pain Severity (Brief Pain Inventory), Bone Pain Interference (Brief Pain Inventory) and 1 more. Started Nov 2024; status: recruiting.
02
Drugs
loratadine
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT05421416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05421416.